Brokerages Set agilon health, inc. (NYSE:AGL) Target Price at $27.95

Shares of agilon health, inc. (NYSE:AGL) have received an average recommendation of “Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Eight analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $27.95.

Several research firms have weighed in on AGL. Deutsche Bank Aktiengesellschaft dropped their price target on agilon health from $28.00 to $27.00 in a research report on Monday, May 15th. TD Cowen dropped their price target on agilon health from $29.00 to $25.00 and set an “outperform” rating for the company in a research report on Tuesday, August 15th. Evercore ISI began coverage on agilon health in a research report on Tuesday, June 13th. They issued an “inline” rating and a $22.50 price objective for the company. Truist Financial lowered their price objective on agilon health from $35.00 to $27.00 in a research report on Tuesday, June 20th. Finally, The Goldman Sachs Group lowered their price objective on agilon health from $29.00 to $25.00 and set a “buy” rating for the company in a research report on Tuesday, August 15th.

Insider Activity at agilon health

In related news, insider Benjamin Shaker sold 18,750 shares of agilon health stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $16.97, for a total value of $318,187.50. Following the transaction, the insider now owns 79,543 shares in the company, valued at $1,349,844.71. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Over the last 90 days, insiders have sold 56,250 shares of company stock worth $1,008,750. 3.60% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Huntington National Bank lifted its stake in shares of agilon health by 241.3% during the second quarter. Huntington National Bank now owns 1,512 shares of the company’s stock worth $26,000 after purchasing an additional 1,069 shares in the last quarter. Signaturefd LLC lifted its stake in shares of agilon health by 58.0% during the first quarter. Signaturefd LLC now owns 1,144 shares of the company’s stock worth $27,000 after purchasing an additional 420 shares in the last quarter. First Horizon Advisors Inc. increased its position in shares of agilon health by 41.2% during the first quarter. First Horizon Advisors Inc. now owns 1,553 shares of the company’s stock worth $37,000 after acquiring an additional 453 shares during the last quarter. Van ECK Associates Corp increased its position in shares of agilon health by 41.5% during the fourth quarter. Van ECK Associates Corp now owns 2,738 shares of the company’s stock worth $44,000 after acquiring an additional 803 shares during the last quarter. Finally, US Bancorp DE increased its position in shares of agilon health by 93.7% during the first quarter. US Bancorp DE now owns 2,425 shares of the company’s stock worth $58,000 after acquiring an additional 1,173 shares during the last quarter.

agilon health Stock Performance

NYSE AGL opened at $18.45 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.50 and a quick ratio of 1.50. The business has a 50 day moving average price of $17.97 and a 200 day moving average price of $21.31. The company has a market capitalization of $7.48 billion, a P/E ratio of -87.85 and a beta of 1.00. agilon health has a 1-year low of $15.00 and a 1-year high of $29.44.

agilon health (NYSE:AGL) last released its quarterly earnings results on Thursday, August 3rd. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.03). The company had revenue of $1.15 billion for the quarter, compared to analysts’ expectations of $1.11 billion. agilon health had a negative return on equity of 8.57% and a negative net margin of 2.39%. Sell-side analysts expect that agilon health will post -0.14 EPS for the current fiscal year.

About agilon health

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.